Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


GoodRx Sees Q1 Adj. EBITDA Margin ~30%, Sales $158M-$161M vs $162M Estimate; FY21 Sales $735M-$755M vs $737.6M Est.


Benzinga | Mar 11, 2021 04:11PM EST

GoodRx Sees Q1 Adj. EBITDA Margin ~30%, Sales $158M-$161M vs $162M Estimate; FY21 Sales $735M-$755M vs $737.6M Est.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC